CytomX Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $1.4 | $10 | $6 | $19 | $51 | $33 | $25 | $41 | |
| −$21 | −$18 | −$14 | −$0.2 | $24 | $5.7 | −$6.5 | $14 | |
| 219 | 177 | 165 | 129 | 87 | 85 | 85 | 83 |
Trend